DOI: 10.1055/s-00000030

Der Klinikarzt

References

Gluz O, Nitz U, Liedtke C. et al.
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.

J Natl Cancer Inst 2018;
110: 628-637

Download Bibliographical Data

Search in:
Access: